Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma
Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma
About this item
Full title
Author / Creator
Publisher
Italy: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Italy: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Precision medicine promises to improve prognosis of patients affected by untreatable diseases. Patients with lung cancer (especially lung adenocarcinoma) bear an increased risk of VTE. Mutations in the EGFR and rearrangement in the ALK genes identify specific subgroups of patients. Aim of this study was to investigate the role of epidermal growth f...
Alternative Titles
Full title
Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d4966c041b514166a24ba14d3dda7040
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d4966c041b514166a24ba14d3dda7040
Other Identifiers
ISSN
2049-6958,1828-695X
E-ISSN
2049-6958
DOI
10.1186/s40248-017-0097-0
